Cargando…
Efficacy and Safety of Rituximab in Chinese Children With Refractory Anti-NMDAR Encephalitis
Purpose: To assess the efficacy and safety of rituximab treatment as second-line immunotherapy in pediatric cases of anti-NMDA receptor (NMDAR) encephalitis. Methods: We retrospectively recruited 8 patients with anti-NMDAR encephalitis who were treated with rituximab as second-line immunotherapy. We...
Autores principales: | Dou, Xiangjun, Li, Dongjing, Wu, Yan, Wang, Zhijing, Yang, Le, Ma, Nan, Wang, Dong, Li, Xia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767921/ https://www.ncbi.nlm.nih.gov/pubmed/33381080 http://dx.doi.org/10.3389/fneur.2020.606923 |
Ejemplares similares
-
Thyroid Function and Anti-thyroid Antibodies in Pediatric Anti-NMDAR Encephalitis
por: Chen, Lianfeng, et al.
Publicado: (2021) -
Concurrent Tuberculous Meningoencephalitis and Anti-NMDAR Encephalitis: A Case Report
por: Xiaoli, Chen, et al.
Publicado: (2022) -
Clinical Features, Treatment, and Outcomes Among Chinese Children With Anti-methyl-D-aspartate Receptor (Anti-NMDAR) Encephalitis
por: Zhang, Min, et al.
Publicado: (2019) -
Neuronal NMDAR Currents of the Hippocampus and Learning Performance in Autoimmune Anti-NMDAR Encephalitis and Involvement of TNF-α and IL-6
por: Wang, Xu, et al.
Publicado: (2019) -
Pharmaceutical care of rituximab in the treatment of children with refractory anti-NMDAR encephalitis: A case report
por: Wu, Haiyan, et al.
Publicado: (2023)